BlackRock Institutional Trust’s Dr. Reddy's Laboratories RDY Stock Holding History

BlackRock Institutional Trust’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$4.58M	Buy	505,625 +15,185	+3%	+$141K	﹤0.01%	2761
2016 Q3	$4.55M	Sell	490,440 -425,745	-46%	-$4.06M	﹤0.01%	2730
2016 Q2	$9.39M	Buy	916,185 +532,535	+139%	+$4.88M	﹤0.01%	2325
2016 Q1	$3.47M	Sell	383,650 -1,304,485	-77%	-$11.7M	﹤0.01%	2817
2015 Q4	$15.6M	Sell	1,688,135 -2,457,490	-59%	-$26.9M	﹤0.01%	2024
2015 Q3	$53M	Buy	4,145,625 +3,874,600	+1,430%	+$48.1M	0.01%	1197
2015 Q2	$3M	Buy	271,025 +97,100	+56%	+$1.07M	﹤0.01%	2957
2015 Q1	$1.99M	Sell	173,925 -699,725	-80%	-$7.42M	﹤0.01%	3117
2014 Q4	$8.81M	Buy	873,650 +777,550	+809%	+$8.19M	﹤0.01%	2436
2014 Q3	$1.01M	Buy	+96,100	New	+$903K	﹤0.01%	3322
2014 Q1	–	Sell	-568,060	Closed	-$4.66M	–	4013
2013 Q4	$4.66M	Buy	568,060 +542,125	+2,090%	+$4.29M	﹤0.01%	2821
2013 Q3	$196K	Sell	25,935 -114,505	-82%	-$833K	﹤0.01%	3680
2013 Q2	$1.06M	Buy	+140,440	New	+$1.03M	﹤0.01%	3320

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

HSBC Holdings London, United Kingdom $239B AUM 42.32% 1-Year Est. Return

BlackRock Institutional Trust's RDY Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Dr. Reddy's Laboratories (RDY) stake by 3.1% in Q4 2016, buying an estimated $141K and bringing the position to 505,625 shares worth $4.58M. The position accounts for ﹤0.01% of the portfolio, ranked #2761.

BlackRock Institutional Trust first reported a position in RDY in Q2 2013 and has held it in 13 quarters since. The position peaked at $53M in Q3 2015. 164 funds tracked by Wall St. Rank hold RDY as of Q4 2016.

BlackRock Institutional Trust held 505,625 shares of Dr. Reddy's Laboratories worth $4.58M as of Q4 2016.
BlackRock Institutional Trust bought 15,185 Dr. Reddy's Laboratories shares in Q4 2016, an estimated $141K.
Dr. Reddy's Laboratories made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2761 holding.
BlackRock Institutional Trust first reported a position in Dr. Reddy's Laboratories in Q2 2013 and has held it in 13 quarters since.
BlackRock Institutional Trust's Dr. Reddy's Laboratories position peaked at $53M in Q3 2015.
164 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.